Cover Image

Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy

Abstract Background For patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of therapy. Initial treatment with platinum chemotherapy and/or an immune checkpoint inhibitor (ICI) is the standard of care for patients without act...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jerome H. Goldschmidt (Author), Wan-Yu Tseng (Author), Yunfei Wang (Author), Janet Espirito (Author), Anupama Vasudevan (Author), Michelle Silver (Author), Jackie Kwong (Author), Ruchit Shah (Author), Elizabeth Marrett (Author)
Format:	Book
Published:	Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens
by: Elizabeth Marrett, et al.
Published: (2023)

Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer
by: S. К. Zyryanov, et al.
Published: (2024)

Immunotherapy regimens for metastatic colorectal carcinomas
by: Babar Bashir, et al.
Published: (2018)

Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
by: Adriana J. Wong, et al.
Published: (2022)

The role of immunotherapy in early-stage and metastatic NSCLC
by: Attila Lieber, et al.
Published: (2024)

Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
by: Yuke Wu, et al.
Published: (2024)

INTRAPLEURAL IMMUNOTHERAPY FOR METASTATIC PLEURISIES IN PATIENTS WITH BREAST CANCER
by: K. S. Titov, et al.
Published: (2014)

[Translated article] Cryosurgery as an Adjuvant to Immunotherapy in Metastatic Melanoma
by: L.P. González-Cardona, et al.
Published: (2023)

Treatment of BRAF-Mutated Metastatic Melanoma: Immunotherapy or Target Therapy?
by: Ana Sofia Rodrigues, et al.
Published: (2021)

Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer
by: Balraj Singh MD, et al.
Published: (2021)

Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer
by: Yangchun Gu, et al.
Published: (2021)

Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapy
by: Min Woo Hwang, et al.
Published: (2024)

Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
by: Xiaoyan Liu, et al.
Published: (2022)

The platinum metals
by: Lumb, Arthur Douglas, -1938

Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma
by: Alexander B. Aria, BS, et al.
Published: (2018)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012)

Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
by: Brittany P. Rickard, et al.
Published: (2023)

Genomic alterations in oral multiple primary cancers
by: Xuan Zhou, et al.
Published: (2024)

Incorporation of immunotherapy into the treatment of metastatic neuroendocrine carcinoma of the cervix: A case report
by: Akanksha Suresh, et al.
Published: (2023)

Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma
by: Johanne Seguin, et al.
Published: (2024)

Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
by: Guilan Shi, et al.
Published: (2022)

Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine
by: Rossiter LF, et al.
Published: (2020)

Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
by: Tito Fojo, et al.
Published: (2020)

Catalytic soot oxidation by platinum on sintered metal filters. Influence of the platinum quantity, particle size and location, and investigation of the platinum-soot contact
by: Hinot, Karelle
Published: (2007)

Clinical experience with pemigatinib for previously treated metastatic cholangiocarcinoma: practical considerations from clinical cases
by: Jonathan Wadsley, et al.
Published: (2023)

Crayon Portraiture Complete Instructions for Making Crayon Portraits on Crayon Paper and on Platinum, Silver and Bromide Enlargements
by: Barhydt, Jerome A.

Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance
by: Yin-Ting Chuang, et al.
Published: (2012)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
by: Amelia M. Jernigan, et al.
Published: (2013)

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines
by: Aaron Praiss, et al.
Published: (2022)

Tumoral melanosis: A case series of patients with metastatic melanoma after systemic immunotherapy
by: Sophia N. Wix, MPhil, et al.
Published: (2024)

Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report
by: Rory Barry, et al.
Published: (2024)

Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy
by: Rakefet Sidlik Muskatel, et al.
Published: (2022)

Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
by: Marianeve Carotenuto, et al.
Published: (2022)

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
by: Weiguang Gu, et al.
Published: (2023)

Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States
by: Neelima Denduluri, et al.
Published: (2022)

Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia
by: Evelien G. E. Hurkmans, et al.
Published: (2023)

Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response
by: Alexandra Picard‐Gauci, et al.
Published: (2022)

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis
by: Peng PJ, et al.
Published: (2014)

GEMCITABINE / PLATINUM VS. VINORELBINE- PLATINUM IN PATIENTS WITH ADVANCED NON- SMALL- CELL LUNG CANCER
by: Deyan Davidov
Published: (2008)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023)